Glucagon-Like Peptide 1 Receptor Agonists and Mental Health: A Systematic Review and Meta-Analysis.
Pierret ACS. et al, (2025), JAMA Psychiatry
Are cognitive behavioural therapy, cognitive therapy, and behavioural activation for depression effective in primary care? A systematic review and meta-analysis.
Carey M. et al, (2025), J Affect Disord, 382, 215 - 226
Clinical and cost-effectiveness of lithium versus quetiapine augmentation for treatment-resistant depression: a pragmatic, open-label, parallel-group, randomised controlled superiority trial in the UK.
Cleare AJ. et al, (2025), Lancet Psychiatry, 12, 276 - 288
Clozapine and treatment-resistant schizophrenia: efficacy versus effectiveness.
Siskind D. et al, (2025), Lancet Psychiatry, 12, 240 - 241
INTEGRATE: international guidelines for the algorithmic treatment of schizophrenia.
McCutcheon RA. et al, (2025), Lancet Psychiatry
A global Delphi guideline for absolute neutrophil count (ANC) and adverse drug reaction (ADR) monitoring during clozapine treatment
McCutcheon R., (2025), The Lancet Psychiatry
Striatal dopamine D2/D3 receptor regulation of human reward processing and behaviour.
Osugo M. et al, (2025), Nat Commun, 16
Anticholinergic Burden and Cognitive Function in Psychosis: A Systematic Review and Meta-Analysis
Mancini V. et al, (2025), American Journal of Psychiatry
The hypothesis of biologically based subtypes of schizophrenia: a 10-year update.
Howes OD. et al, (2025), World Psychiatry, 24, 46 - 47
An analysis on the role of glucagon-like peptide-1 receptor agonists in cognitive and mental health disorders
De Giorgi R. et al, (2025), Nature Mental Health
Investigating dopaminergic abnormalities in schizophrenia and first-episode psychosis with normative modelling and multisite molecular neuroimaging
Giacomel A. et al, (2025), Molecular Psychiatry
Radiomic Analysis of Striatal [18F]FDOPA PET Imaging in Patients with Psychosis for the Identification of Antipsychotic Response
Schiulaz A. et al, (2025), Molecular Imaging and Biology
Correction: Longitudinal change in neurocognitive functioning in children and adolescents at clinical high risk for psychosis: a systematic review.
Pedruzo B. et al, (2024), Eur Child Adolesc Psychiatry
Psychotropic Taxonomies: Constructing a Therapeutic Framework for Psychiatry.
McCutcheon RA. et al, (2024), Biol Psychiatry
Metformin for the Prevention of Antipsychotic-Induced Weight Gain: Guideline Development and Consensus Validation.
Carolan A. et al, (2024), Schizophr Bull
Deconstructing Cognitive Impairment in Psychosis With a Machine Learning Approach
McCutcheon RA. et al, (2024), JAMA Psychiatry